Sho Okamoto

773 total citations
49 papers, 584 citations indexed

About

Sho Okamoto is a scholar working on Neurology, Rheumatology and Psychiatry and Mental health. According to data from OpenAlex, Sho Okamoto has authored 49 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 23 papers in Rheumatology and 11 papers in Psychiatry and Mental health. Recurrent topics in Sho Okamoto's work include Intracranial Aneurysms: Treatment and Complications (21 papers), Moyamoya disease diagnosis and treatment (19 papers) and Neurological Complications and Syndromes (11 papers). Sho Okamoto is often cited by papers focused on Intracranial Aneurysms: Treatment and Complications (21 papers), Moyamoya disease diagnosis and treatment (19 papers) and Neurological Complications and Syndromes (11 papers). Sho Okamoto collaborates with scholars based in Japan, United States and Italy. Sho Okamoto's co-authors include Yoshio Araki, Toshihiko Wakabayashi, Kenji U�da, Kinya Yokoyama, Kazuhiro Yoshikawa, Takashi Izumi, Shinsuke Muraoka, Junji Yoshida, Takashi Takahashi and Shinya Kimura and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Sho Okamoto

46 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sho Okamoto Japan 16 256 255 167 121 97 49 584
Lorenz Thurner Germany 16 82 0.3× 235 0.9× 28 0.2× 91 0.8× 157 1.6× 63 730
T Uede Japan 14 116 0.5× 145 0.6× 50 0.3× 37 0.3× 91 0.9× 49 544
Pierangelo Barbero Italy 15 289 1.1× 408 1.6× 31 0.2× 36 0.3× 63 0.6× 34 951
H.-F. Petereit Germany 14 121 0.5× 190 0.7× 24 0.1× 41 0.3× 47 0.5× 29 594
V. S. Mehta India 19 127 0.5× 303 1.2× 32 0.2× 90 0.7× 117 1.2× 44 823
M. Stojanovic Serbia 8 249 1.0× 361 1.4× 33 0.2× 16 0.1× 72 0.7× 18 1.0k
Linda E. Ansbacher United States 12 116 0.5× 346 1.4× 28 0.2× 133 1.1× 60 0.6× 19 554
Bella Ertik United States 5 236 0.9× 286 1.1× 27 0.2× 19 0.2× 69 0.7× 7 930
Tamara Miller United States 6 247 1.0× 319 1.3× 24 0.1× 19 0.2× 65 0.7× 23 958
Hayato Yamazaki Japan 10 211 0.8× 311 1.2× 13 0.1× 52 0.4× 47 0.5× 14 602

Countries citing papers authored by Sho Okamoto

Since Specialization
Citations

This map shows the geographic impact of Sho Okamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Okamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Okamoto more than expected).

Fields of papers citing papers by Sho Okamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sho Okamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Okamoto. The network helps show where Sho Okamoto may publish in the future.

Co-authorship network of co-authors of Sho Okamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Sho Okamoto. A scholar is included among the top collaborators of Sho Okamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Okamoto. Sho Okamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ureshino, Hiroshi, Makoto Fukuda, Mariko Miyazaki, et al.. (2023). Type II Cryoglobulinemic Membranoproliferative Glomerulonephritis Caused by Mucosa-associated Lymphoid Tissue Lymphoma. Internal Medicine. 62(13). 1983–1988. 1 indexed citations
3.
Katsuya, Hiroo, Hideaki Nakamura, Hidekazu Itamura, et al.. (2023). HTLV‐1 cell‐free DNA in plasma as a potential biomarker in HTLV‐1 carriers and adult T‐cell leukemia‐lymphoma. SHILAP Revista de lepidopterología. 4(3). 733–737. 3 indexed citations
4.
Tahara, Yuhei O., Sho Okamoto, Taku Oshima, et al.. (2023). Relationship between the Rod complex and peptidoglycan structure in Escherichia coli. MicrobiologyOpen. 12(5). e1385–e1385. 7 indexed citations
5.
Muraoka, Shinsuke, Yoshio Araki, Kenji U�da, et al.. (2022). Blood flow stagnation after treatment of a giant internal carotid artery aneurysm: a computed fluid dynamics analysis. Scientific Reports. 12(1). 7283–7283. 5 indexed citations
6.
Araki, Yoshio, et al.. (2021). Ipsilateral late stroke after revascularization surgery for patients with Moyamoya disease. Acta Neurochirurgica. 163(5). 1493–1502. 4 indexed citations
7.
Araki, Yoshio, Kenji U�da, Kinya Yokoyama, et al.. (2020). Surgical Designs of Revascularization for Moyamoya Disease: 15 Years of Experience in a Single Center. World Neurosurgery. 139. e325–e334. 15 indexed citations
8.
Araki, Yoshio, Kinya Yokoyama, Kenji U�da, et al.. (2019). Brain Compression by Encephalo-Myo-Synangiosis is a Risk Factor for Transient Neurological Deficits After Surgical Revascularization in Pediatric Patients with Moyamoya Disease. World Neurosurgery. 133. e558–e566. 11 indexed citations
9.
Okamoto, Sho, Hiroshi Ureshino, Hidekazu Itamura, et al.. (2019). Clinical impact of the CONUT score in patients with multiple myeloma. Annals of Hematology. 99(1). 113–119. 39 indexed citations
10.
Muraoka, Shinsuke, Yoshio Araki, Toshiaki Taoka, et al.. (2018). Prediction of Intracranial Arterial Stenosis Progression in Patients with Moyamoya Vasculopathy: Contrast-Enhanced High-Resolution Magnetic Resonance Vessel Wall Imaging. World Neurosurgery. 116. e1114–e1121. 24 indexed citations
11.
Sakamoto, Yusuke, et al.. (2018). Comparative Prospective Study of Microvascular Anastomosis Training by Self-Learning or with Expert Instruction. World Neurosurgery. 118. e818–e824. 6 indexed citations
12.
Ito, Yuichi, Yoshio Araki, Takashi Izumi, et al.. (2018). Case of Subarachnoid Hemorrhage from Ruptured Oncotic Fusiform Aneurysms from Choriocarcinoma Metastasis Treated with Aneurysmectomy and Vessel Reconstruction. World Neurosurgery. 113. 98–102. 3 indexed citations
13.
Wada, Kentaro, Koji Osuka, Yasuo Watanabe, et al.. (2017). Subarachnoid hemorrhage induces neuronal nitric oxide synthase phosphorylation at Ser1412 in the dentate gyrus of the rat brain. Nitric Oxide. 81. 67–74. 10 indexed citations
14.
Yokoyama, Kinya, Kazuhiro Yoshikawa, Yoshio Araki, et al.. (2017). Elevation of Proenkephalin 143–183 in Cerebrospinal Fluid in Moyamoya Disease. World Neurosurgery. 109. e446–e459. 8 indexed citations
15.
Muraoka, Shinsuke, Yoshio Araki, Takashi Izumi, et al.. (2016). Cerebral Infarction and Subarachnoid Hemorrhage Caused by Central Nervous System Aspergillus Infection. World Neurosurgery. 90. 705.e9–705.e13. 11 indexed citations
16.
Uozumi, Yoichi, Sho Okamoto, Yoshio Araki, et al.. (2015). Treatment of Symptomatic Bilateral Cavernous Carotid Aneurysms: Long-term Results of 6 Cases. Journal of Stroke and Cerebrovascular Diseases. 24(5). 1013–1018. 8 indexed citations
17.
Yoshikawa, Kazuhiro, et al.. (2014). Biomarker Research for Moyamoya Disease in Cerebrospinal Fluid Using Surface-enhanced Laser Desorption/Ionization Time-of-flight Mass Spectrometry. Journal of Stroke and Cerebrovascular Diseases. 24(1). 104–111. 20 indexed citations
18.
19.
Yoshikawa, Kazuhiro, Kazuyasu Nakamura, Nobuo Hanai, et al.. (2000). Production of a Single‐chain Variable Fragment Antibody Recognizing Type III Mutant Epidermal Growth Factor Receptor. Japanese Journal of Cancer Research. 91(10). 1035–1043. 23 indexed citations
20.
Okamoto, Sho, Kazuhiro Yoshikawa, Yuuki Obata, et al.. (1996). Monoclonal antibody against the fusion junction of a deletion-mutant epidermal growth factor receptor. British Journal of Cancer. 73(11). 1366–1372. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorenz Thurner Breakdown of academic impact, for papers by T Uede Breakdown of academic impact, for papers by Pierangelo Barbero Breakdown of academic impact, for papers by H.-F. Petereit Breakdown of academic impact, for papers by V. S. Mehta Breakdown of academic impact, for papers by M. Stojanovic Breakdown of academic impact, for papers by Linda E. Ansbacher Breakdown of academic impact, for papers by Bella Ertik Breakdown of academic impact, for papers by Tamara Miller Breakdown of academic impact, for papers by Hayato Yamazaki
Rankless by CCL
2026